Jamie Barcombe is a European and Chartered (UK) Patent Attorney with a background in biotechnology. His experience extends to drafting, prosecuting and opposing European patent applications directed to a wide array of technologies, including nucleotide therapies, stem cells and biomarkers.
Prior to joining Finnegan, Jamie worked for another large patent law firm in the U.K. He is adept in patent drafting, prosecution, and opposition, and providing strategic advice to clients ranging from global pharmaceutical companies to startups. Jamie has experience managing international portfolios for clinical and pre-clinical candidates and pursuing protection for the candidates themselves in addition to their medical uses, manufacturing methods, and patient subgroups.
Jamie’s technical expertise spans the life sciences, covering biologics, biotechnology, clean energy, food and beverage, textiles and pharmaceuticals. He previously worked in research and development (R&D) for a multinational pharmaceutical company and practiced intellectual property management for a world-leading animal health institute, as well as conducted academic research investigating the delivery of therapeutic nucleotides.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
